BNTC News and Press, Benitec Biopharma Limited From 09/20/21

Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results PR Newswire HAYWARD, Calif. , Sept. 20, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene t...

Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference PR Newswire HAYWARD, Calif. , Sept. 13, 2021 /PRNewswire/ -- Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company develo...

Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022 PR Newswire HAYWARD, Calif. , Sept. 8, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of...

Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals PR Newswire HAYWARD, Calif. , Sept. 8, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancem...

Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022 PR Newswire HAYWARD, Calif. , Sept. 8, 2021 /PRNewswire/ -- Regulatory Update Highlights: ...

Palisade Bio (PALI) +36% on FDA's fast track designation for LB1148.Fuel Tech (FTEK) +21% on Q1 results.Lianluo Smart (LLIT) +20%.Celyad Oncology SA (CYAD) +20%.Vertex Energy (VTNR) +18% on Q1 results.InnSuites Hospitality Trust (IHT) +15%.Heron Therapeutics (HRTX) +15% on...

Gainers: Brooklyn ImmunoTherapeutics (BTX) +44%.Uxin (UXIN) +25%.Ashford Hospitality Trust (AHT) +24%.Boxlight (BOXL) +21%.ADMA Biologics (ADMA) +18%.Clover Health Investments (CLOV) +16%.Unitil (UTL) +15%.Pitney Bowes (PBI) +15%.ClearSign Technologies (CLIR) +15%.Microvision (MVIS) ...

Gainers: ADMA Biologics (ADMA) +25%, Brooklyn ImmunoTherapeutics (BTX) +23%, Clover Health Investments (CLOV) +15%, Neptune Wellness Solutions (NEPT) +12%, Akouos (AKUS) +11%.Losers: Protalix BioTherapeutics (PLX) -40%, Benitec Bioph...

Protalix BioTherapeutics (PLX) -43% on FDA rejection of experimental therapy for Fabry disease.Benitec Biopharma (BNTC) -22% after secures $13M capital via equity offering.Urban Tea (MYT) -13% on 1H earnings releasePinterest (PINS) -12% on Q1 earnings releas...

Benitec Biopharma's (BNTC) underwriter has agreed to increase the size of the previous offering and purchase on a firm commitment basis ~3M shares of common stock at $4.25/share.Expected gross proceeds are ~$12.9MUnderwriter's over-allotment is an additional ~455.5K shares. Net proceeds will ...